Unmet Needs in IgAN: Burden of Disease & Long-Term Impact on Patients ft. Dr. Jonathan Barratt : 2 episode artwork

EPISODE · Apr 24, 2024 · 15 MIN

Unmet Needs in IgAN: Burden of Disease & Long-Term Impact on Patients ft. Dr. Jonathan Barratt : 2

from Rare Kidney Disease Show · host Travere Therapeutics

Overview:In this episode of the Rare Kidney Disease Show, Professor Jonathan Barratt discusses the need to take a long-term approach when managing IgA nephropathy patients. He presents data from the UK National Registry of Rare Kidney Diseases (RaDaR). During this recording you will hear Professor Barratt discussing the continued risk of progression to end stage renal disease even in patients with proteinuria of less than 1g/day, the current threshold of high risk as per KDIGO guidelines. The data from the UK has been reinforced by recent database studies and these will also be discussed by Professor Barratt.Key Quotes: "If you have IgA Nephropathy and you're diagnosed as a child, half of those children have developed kidney failure at 20 years.""We need to be thinking, what is it like for that patient in front of us being 50 or 60, not necessarily what's going to happen in the next five or ten years.""If we don't think the longer term, we're going to under-treat and not serve our patients well." Key Takeaways:IgA nephropathy patients often have decades of life ahead of them, so physicians should focus on minimizing lifetime risk of kidney failure rather than short-term outcomes (00:02:11)RaDaR data shows high rates of kidney failure among IgA nephropathy patients in the UK, even those diagnosed and treated as children (00:04:05)Per the RaDaR publication, an eGFR decline of <1 ml/min per 1.73 m2 per year must be the target if patients are to avoid kidney failure (00:06:48)In the UK, 1 in 4 IgA nephropathy patients with 0.5-1 g/day proteinuria reach ESRD within 10 years (00:08:23)Recent US database searches confirm high rates of CKD progression and kidney failure in IgA nephropathy patients, even those with lower proteinuria levels (00:13:20)Disclaimer: Guest speakers of the Rare Kidney Disease Show may be paid consultants of Travere Therapeutics. This podcast episode was recorded on April 24, 2024. Please always consult updated sources for the latest information, as information discussed may have changed since the recording date.

Overview:In this episode of the Rare Kidney Disease Show, Professor Jonathan Barratt discusses the need to take a long-term approach when managing IgA nephropathy patients. He presents data from the UK National Registry of Rare Kidney Diseases (RaDaR). During this recording you will hear Professor Barratt discussing the continued risk of progression to end stage renal disease even in patients with proteinuria of less than 1g/day, the current threshold of high risk as per KDIGO guidelines. The data from the UK has been reinforced by recent database studies and these will also be discussed by Professor Barratt.Key Quotes: "If you have IgA Nephropathy and you're diagnosed as a child, half of those children have developed kidney failure at 20 years.""We need to be thinking, what is it like for that patient in front of us being 50 or 60, not necessarily what's going to happen in the next five or ten years.""If we don't think the longer term, we're going to under-treat and not serve our patients well." Key Takeaways:IgA nephropathy patients often have decades of life ahead of them, so physicians should focus on minimizing lifetime risk of kidney failure rather than short-term outcomes (00:02:11)RaDaR data shows high rates of kidney failure among IgA nephropathy patients in the UK, even those diagnosed and treated as children (00:04:05)Per the RaDaR publication, an eGFR decline of <1 ml/min per 1.73 m2 per year must be the target if patients are to avoid kidney failure (00:06:48)In the UK, 1 in 4 IgA nephropathy patients with 0.5-1 g/day proteinuria reach ESRD within 10 years (00:08:23)Recent US database searches confirm high rates of CKD progression and kidney failure in IgA nephropathy patients, even those with lower proteinuria levels (00:13:20)Disclaimer: Guest speakers of the Rare Kidney Disease Show may be paid consultants of Travere Therapeutics. This podcast episode was recorded on April 24, 2024. Please always consult updated sources for the latest information, as information discussed may have changed since the recording date.

NOW PLAYING

Unmet Needs in IgAN: Burden of Disease & Long-Term Impact on Patients ft. Dr. Jonathan Barratt : 2

0:00 15:44

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

MG Show MG Show The MG Show, hosted by Jeffrey Pedersen and Shannon Townsend, is a leading alternative media platform dedicated to uncovering the truth behind today’s most pressing political issues. Launched in 2019, the show has grown exponentially, offering unfiltered insights, comprehensive research, and real-time analysis. With a commitment to independent journalism and factual integrity, the MG Show empowers its audience with knowledge and encourages active participation in the political discourse. Breaking News Show | eTurboNews Juergen Thomas Steinmetz News is relevant to the global travel and tourism industry, human rights and global issues.Breaking news when it happens and only from the source. PodQuesting Dwight J Randolph- WolfShield Media PodQuesting: -By WolfShield Media and Dwight J RandolphJoin us on an exciting journey to master the world of fiction podcasting! At PodQuesting, we document our quest to improve and innovate, sharing valuable insights, strategies, and behind-the-scenes tips along the way. Whether you're an experienced podcaster or just starting your first show, our podcast is your go-to resource for everything podcasting.Discover practical advice, creative techniques, and lessons from our own experiences as we explore the ever-evolving podcasting landscape. Ready to level up your skills and embark on this adventure with us? Tune in and join the quest!Have questions or feedback? Reach out to us at [email protected] and visit our website:WolfShield.Media Denn sie wissen was sie wandern Manuel Andrack Alles über Premiumwanderwege, die schönsten Wege in Deutschland. Sensationelle Outdoor-Erlebnisse auf 750 Premiumwegen. Moderiert von Manuel Andrack (Sidekick der Harald Schmidt Show) und Klaus Erber (Vorsitzender des Deutschen Wanderinstituts.)

Frequently Asked Questions

How long is this episode of Rare Kidney Disease Show?

This episode is 15 minutes long.

When was this Rare Kidney Disease Show episode published?

This episode was published on April 24, 2024.

What is this episode about?

Overview:In this episode of the Rare Kidney Disease Show, Professor Jonathan Barratt discusses the need to take a long-term approach when managing IgA nephropathy patients. He presents data from the UK National Registry of Rare Kidney Diseases...

Can I download this Rare Kidney Disease Show episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!